Company news

Ningbo Menovo Pharmaceutical Co., Ltd. Class A (SSE:603538) news

Ningbo Menovo Pharmaceutical Co., Ltd. Class A news releases on 6ix. Latest, Sep 30, 2026: "Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on Change…

Ningbo Menovo Pharmaceutical Co., Ltd. Class A (SSE:603538) news

Press releases & updates

"Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on Change of Sponsor and Sponsor Representative

"Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing

"Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on the Dilution of Immediate Returns, Measures to Mitigate Such Dilution and the Undertakings by Relevant Parties in Relation to the 2026 Private Placement of A-Shares (Revised Draft)

"Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on Completion of the Industrial and Commercial Registration Change and Issuance of a New Business License

"Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026

"Ningbo Menovo Pharmaceutical Co., Ltd."Notice on Convening the 2nd Extraordinary General Meeting in 2026

"Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on Resolutions of the 30th Meeting of the 5th Board of Directors

"Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on the Proposed Selection of the Wholly-owned Subsidiary in the 12th Batch of National Centralized Drug Procurement

"Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on Change to "Drug Manufacturing License" of Controlled Subsidiary

"Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on Progress in Outward Investment

"Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on Abnormal Fluctuations in Stock Trading

"Ningbo Menovo Pharmaceutical Co., Ltd."Announcement on External Investment

Announcement on the Lifting and Listing of the 2nd Trade Restriction Period for Restricted Shares Granted under the Initial Granting of the 2024 Restricted Stock Incentive Plan

Announcement on No Provision of Financial Aid or Compensation for Investors Participating in Subscription Directly or through Stakeholders in This Issuance of A Shares to Specific Objects

Announcement on Convening Performance Briefing for 2025 and Q1 2026

Announcement on Completing Industrial and Commercial Change Registration and Obtaining New Business License

Announcement on the Lifting and Listing of the 1st Trade Restriction Period for Restricted Shares Granted under the Reserved Granting of the 2024 Restricted Stock Incentive Plan

Announcement on Abnormal Fluctuations in Stock Trading

Announcement on Resolutions of the 27th Meeting of the 5th Board of Directors

Announcement on Progress in Using Idle Raised Funds for Cash Management

Announcement on Resolutions of the 2025 Annual General Meeting

Announcement on Redemption Results of “MENOVO Convertible Bonds" and Share Capital Changes

The Last Indicative Announcement on Implementation of Redemption and Delisting of "MENOVO Convertible Bonds"

the 8th Indicative Announcement on Implementation of Redemption and Delisting of "MENOVO Convertible Bonds"

the 7th Indicative Announcement on Implementation of Redemption and Delisting of "MENOVO Convertible Bonds"

the 6th Indicative Announcement on Implementation of Redemption and Delisting of "MENOVO Convertible Bonds"

Announcement on the Cumulative Number of Shares Converted from Convertible Bonds Reaching 10% of the Total Issued Shares Before Conversion and the Associated Share Changes

2025 Annual Report

The 3rd Indicative Announcement on Implementation of Redemption and Delisting of "MENOVO Convertible Bonds"

The 2nd Indicative Announcement on Implementation of Redemption and Delisting of "MENOVO Convertible Bonds"

the 1st Indicative Announcement on Implementation of Redemption and Delisting of "MENOVO Convertible Bonds"

Announcement on Implementation of Redemption and Delisting of "MENOVO Convertible Bonds"

Announcement on Redeeming "MENOVO Convertible Bonds" in Advance

Indicative Announcement on "MENOVO Convertible Bonds" Expected to Meet Conditions for Redemption

Announcement on Conversion Result of Convertible Bonds and Share Changes

Announcement on Abnormal Fluctuation of Convertible Bond Trading and Risk Warning in Stock Trading

Indicative Announcement on the Completion of Cancellation of Repurchased Shares and Passive Change in Equity of Shareholder with Over 5% Shares Reaching an Integral Multiple of 1%

Announcement on Selection of Products of the Wholly-owned Subsidiary for Continuation Procurement Under National Procurement Scheme After Agreement Expiry

Announcement on the Implementation of Repurchase and Cancellation of Equity Incentive Restricted Stocks

Announcement on Not Revising the Downward Conversion Price of "Menovo Convertible Bonds"

Announcement on Relocation of Company Office Premises

Announcement on the Holding Subsidiary Re-certified as High-tech Enterprise

Announcement on Expected Increase in Performance for 2025

Announcement on the Subsidiary Re-certified as High-tech Enterprise

Notice on Convening the 1st Extraordinary General Meeting in 2026

Announcement on Wholly-owned Subsidiary Obtaining Drug Registration Certificate for Adempas Riociguat Tablets

Indicative Announcement on the Expected Meeting of Conditions for Downward Correction of Conversion Price for "Menovo Convertible Bonds"

in 2026

Announcement on Self-exercise Results of Initially Granted Portion in the 3rd Exercise Period of the 2021 Stock Option Incentive and Restricted Stock Plan and Share Changes

Announcement on Resolutions of the 22nd Meeting of the 5th Board of Directors